These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 9212825

  • 21. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L, Xi-Ran Z.
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [Abstract] [Full Text] [Related]

  • 22. TPA-induced differentiation of human rhabdomyosarcoma cells involves dephosphorylation and nuclear accumulation of mutant P53.
    Germani A, Fusco C, Martinotti S, Musarò A, Molinaro M, Zani BM.
    Biochem Biophys Res Commun; 1994 Jul 15; 202(1):17-24. PubMed ID: 8037710
    [Abstract] [Full Text] [Related]

  • 23. Assessment of p53 expression in nasopharyngeal carcinoma.
    Sheu LF, Chen A, Tseng HH, Leu FJ, Lin JK, Ho KC, Meng CL.
    Hum Pathol; 1995 Apr 15; 26(4):380-6. PubMed ID: 7705815
    [Abstract] [Full Text] [Related]

  • 24. p53 transactivation through various p53-responsive elements.
    Park DJ, Chumakov AM, Miller CW, Pham EY, Koeffler HP.
    Mol Carcinog; 1996 Jun 15; 16(2):101-8. PubMed ID: 8645424
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
    Lepelley P, Preudhomme C, Vanrumbeke M, Quesnel B, Cosson A, Fenaux P.
    Leukemia; 1994 Aug 15; 8(8):1342-9. PubMed ID: 8057671
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES, Lai CR, Hsieh YT, Chen JT, Lin AJ, Hung MH, Liu FS.
    Gynecol Oncol; 2001 Feb 15; 80(2):189-93. PubMed ID: 11161858
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC.
    Van Tornout JM, Spruck CH, Shibata A, Schmutte C, Gonzalez-Zulueta M, Nichols PW, Chandrasoma PT, Yu MC, Jones PA.
    Cancer Epidemiol Biomarkers Prev; 1997 Jul 15; 6(7):493-7. PubMed ID: 9232335
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Improved detection of p53 point mutations by dideoxyfingerprinting (ddF).
    Martincic D, Whitlock JA.
    Oncogene; 1996 Nov 07; 13(9):2039-44. PubMed ID: 8934553
    [Abstract] [Full Text] [Related]

  • 35. p53 mutation in human nasopharyngeal carcinomas.
    Lo KW, Mok CH, Huang DP, Liu YX, Choi PH, Lee JC, Tsao SW.
    Anticancer Res; 1992 Nov 07; 12(6B):1957-63. PubMed ID: 1295443
    [Abstract] [Full Text] [Related]

  • 36. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
    Qu JH, Zhu MH, Lin J, Ni CR, Li FM, Zhu Z, Yu GZ.
    Ai Zheng; 2004 May 07; 23(5):502-7. PubMed ID: 15142443
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB, LaBate M, Liu F, Osterndorff E.
    Mol Carcinog; 1996 Aug 07; 16(4):197-202. PubMed ID: 8784462
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.